Showing results (651-660 of 1,120) with videos related to

Sort By:
Pageof 112
Annals of Internal Medicine|June 3, 2014
Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic reviewSana M Al-Khatib, Nancy M Allen LaPointe, Ranee Chatterjee, et al.
The American Journal of Medicine|January 28, 2010
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromesRenato D Lopes, Aijing Starr, Carl F Pieper, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|March 1, 1997
Gradual bone distraction in craniosynostosis. Preliminary results in seven casesC M do Amaral, G Di Domizio, V Tiziani, et al.
American Heart Journal|March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationaleRenato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
Cardiovascular Drugs and Therapy|August 22, 2018
The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up StudyJose C Nicolau, Remo H M Furtado, Luciano M Baracioli, et al.
JAMA Cardiology|February 27, 2020
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysisRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
Journal of the American College of Cardiology|November 12, 2013
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)Greg Flaker, Renato D Lopes, Sana M Al-Khatib, et al.
JACC. Cardiovascular Interventions|May 11, 2019
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance DocumentErnest Spitzer, Eugene McFadden, Pascal Vranckx, et al.
Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
Pageof 112